OxyContin maker Purdue Pharma may settle legal claims with a new ‘public trust’ that would still be dedicated to profit
Two similarly ambitious efforts to build alternatives to the profit-driven pharmaceutical model during and immediately after World War II suggest …
Why Americans pay more for prescription drugs than anywhere else globally
The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high
Microplastics all around: A silent epidemic
All types of sea creatures ingest microplastics; as they move up the food chain, the plastic ends up in the human gut
Bedaquiline patent win is a half victory
India’s ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy
Fake medicines are a dangerous threat in Africa: 3 ways to spot them
The most common fakes tend to be the most popular medicines: Painkillers, antibiotics to treat infection, anti-malarials, anti-retrovirals, …
When Big Pharma has all the answers
IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …
Big Pharma and intellectual property: Why is India afraid of compulsory licences?
While rich nations are discovering the virtues of compulsory drug licences, India has resolutely turned its back on this tool despite nudges from …
AI for drug development: How trustworthy is the tech?
Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half
Dark underbelly of Big Pharma lobbying
Recent protests and campaigns in the US have focused on the proposal by India & South Africa at WTO to keep TRIPS in abeyance till the …
Rise of AMR could result in up to 10 million annual deaths by 2050: UN report
Some 24 million people could be pushed into extreme poverty due to rising AMR, the UNEP said
The end of meat and GMOs or the end of us: Part 1
The first in a three-part series series on effects of GMOs and the meat industry on our environment
AMR driven by manufacturing our next big challenge
Antibiotics production is an important yet often forgotten driver of antimicrobial resistance; an alliance of pioneers has decided to pave the …
National List of Essential Medicines: 34 drugs enlisted in update after 7 years
The latest National List of Essential Medicines features 384 medicines, drops 26 old ones
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Antimicrobial resistance: The need to tackle access-excess problem
AMR, like every process, has its own drivers and determinants. The threat has evolved over time due to our acts of omission and commission
Accident at Sainor unit in Vizag more proof of companies bypassing rules
Life-saving equipments were absent on-site though the company had approvals to show they were present
Marxists vs Paternalists vs Liberals: Where healthcare stands in India
How health as a right, investment and consumption regularly crops up in capitalist discourses
More give than take in secret trade deals
The tight secrecy over trade negotiations means citizens are not privy to the deals that affect them directly
Pharma is getting high on marijuana
As drug companies develop cannabis-based medicines for serious illnesses, generic firms are trying to get into the act
Suspect claims in Teva’s suit against Cipla
The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively
